Ginkgo biloba extract , Ginkgo biloba P.E - GBE Specificaton & Trade Terms
| Model | GBE |
|---|
| Place Of Origin | China |
|---|
| Packaging | aluminum foil bag or 25kg/drum. |
|---|
| Brand | HUIR |
|---|
| Certifications | ISO9001(SGS), UKAS, GMP(NSF), KOSHER, HALAL, FDA |
|---|
| Price Term | EX-Work |
|---|
| Payment Term | T/T |
|---|
| Supply Ability | 1000kg per week |
|---|
| Minimum Order | 1kg |
|---|
| Loading Ports | BEIJING |
|---|
| Delivery Time | within 7 days after payment |
|---|
Product Name
Ginkgo Biloba Extract
Latin Name
Ginkgo Biloba L.
Part of used
Leaf
Appearance
Brownish yellow fine powder
Specification
24%/6%Flavonoides/Lactone CP10
Active Ingredient
Quercetin11.5%
Kaempferol12.5%
Isorhamnetin1.74%
Ginkgolide A 1.84%
Ginkgolide B 0.77%
Ginkgolide C 1.62%
Bilobalide 2.3%
Test Method
HPLC
Application
Pharmaceutical, health products, cosmetic
Certificate
ISO9001(SGS), UKAS, GMP(NSF), KOSHER, HALAL, FDA
Packing
Small quantity with double plastic-bag inside and aluminum foil bag outside. Large quantity with 25kg/drum, or depends on clients requirement.
Storage
Store in cool and dry place and avoid light and heat.
Shelf Life
24 months
Benefits
1.Improving blood circulation
2.Treating coronary disease and angina pectoris
3.Treating acute cerebral infarction (ACI)
4.Antioxidant
5.Antiaging
6.Relieving premenstrual syndrome(PMS)
7.Improving sexual function
8.Protecting eyesight, treating retinal arteriosclerosis
9.Lowering high blood pressure, treating diabetes and senile dementia.
Introduction
Ginkgo Biloba Extract contain flavonoid glycosides (myricetin and quercetin) and terpenoids (ginkgolides, bilobalides). These extracts are shown to exhibit reversible, nonselective monoamine oxidase inhibition, as well as inhibition of reuptake at the serotonin, dopamine, and norepinephrine transporters, with all but the norepinephrine reuptake inhibition fading in chronic exposure. Ginkgo extract has in addition been found to act as a selective 5-HT1A receptor agonist in vivo. In 2010, a meta-analysis of clinical trials has shown Ginkgo to be moderately effective in improving cognition in dementia patients but not preventing the onset of Alzheimer's disease in people without dementia.
